Monitor Quote Charts Trades News Financials Toplists Alerts Portfolio Level 2 Forex Boards   22/11/2009 05:15:34 Site map   Help   Financials Sector Sheet Search by Sector FilterX For help & enquiries: 1-888-99-ADVFN (toll free)

Neuropharm Company Financial Information Neuropharm share price | Neuropharm company information | Neuropharm Share Charts | Neuropharm Share News  Company name:  Neuropharm  EPIC:  NPH  Trading Currency:  GBX  Market Sector:  AIM  ISIN:  GB00B1NPJJ01  Market Segment:  AIM  Share Type:  DE  WWW Address:  http://www.neuropharm.co.uk/  Description:  ORD 10P  Industry Sector:  PHARMACEUTICALS & BIOTECHNOLOGY  Price  Price Change [%]  Bid  Ask  Open  High  Low  Volume  16.25   -0.25 [-1.52]  15.00  17.50  16.50  16.50  16.25  6,904  Market Cap. [m]  Shares In Issue [m]  Beta  EPS  DPS  PE Ratio  Yield  52-Wks-Range  5.12  31.54  1.70  -13.30  -  -  -  142.00 - 5.00 Neuropharm Key Figures (at previous day's close) Market Cap. 5.12 m Shares In Issue 31.54 m Prev. Close 16.50 PE Ratio -   Dividend Yield - % EPS - basic -13.30 p Dividend PS - p Dividend Cover -   Cash Flow PS -18.21 p Return On Equity (ROE) -33.11 % Operating Margin - % PEG Factor -   EPS Growth Rate - % Dividends PS Growth Rate - % Net Debt -1.72 m Gross Gearing 10.14 % Quick Assets 4.35 m Net Working Capital 3.02 m Intangibles / Fixed Assets 0.43 % Turnover PS - p Pre-Tax Profit PS -15.68 p Retained Profit PS -13.29 p Cash PS 9.99 p Net Cash PS 5.76 p Net Tangible Asset Value PS * 40.00 p Net Asset Value PS 40.14 p Spread 2.50 (14.29%)   * Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies. Neuropharm Balance Sheet Neuropharm Share Price Sample Period † High Low 1 week 18.50 16.00 4 weeks 23.50 14.50 12 weeks 36.00 14.50 1 year 142.00 5.00 Neuropharm Share Price (5 years) Neuropharm Historic Returns Giorni da oggi † Open Change % Open Avg. Avg. Daily Vol [m] Total Vol [m] VWAP 1 week 18.50 -2.25 -12.16 16.70 0.02 - 16.55 4 weeks 19.50 -3.25 -16.67 17.69 0.03 - 17.25 12 weeks 34.00 -17.75 -52.21 22.75 0.07 - 25.69 26 weeks 14.25 2.00 14.04 22.69 0.09 - 24.35 1 year 142.00 -125.75 -88.56 42.13 0.11 - 17.72 3 years 140.00 -123.75 -88.39 124.13 0.05 - 51.10 5 years 140.00 -123.75 -88.39 124.13 0.05 - 51.10 † periods calculated are whole weeks rather than calendar months Neuropharm Key Management Ratios Neuropharm Investment Ratios (Market value analysis) at previous day's close PQ Ratio -   PE Ratio -   Tobin's Q Ratio 0.32   Tobin's Q Ratio (excl. intangibles) 0.32   Dividend Yield - % Market-to-Book Ratio 0.40   Price-to-Pre-Tax Profit PS -1.04   Price-to-Retained Profit PS -1.22   Price-to-Cash Flow PS -0.89   Price-to-Sales PS -   Price-to-Net Tangible Asset Value PS 0.41   Price-to-Cash PS 1.63   Net Working Capital PS 9.58   Price Pct to Working Capital PS 1.70 % Earnings Yield - % Average PE -   Years in average -   PE to PE average - % Neuropharm Financial Ratios (Leverage Ratios) Debt Ratio 0.76 % Debt-to-Equity Ratio 0.01   Debt-to-Equity Ratio (excl. Intgbl) 0.01   Debt-to-Equity Market Value 0.02   Net Gearing -12.22 % Net Gearing (excl. Intangibles) -12.25 % Gross Gearing 10.14 % Gross Gearing (excl. Intangibles) 10.17 % Gearing Under 1 Year 9.46 % Gearing Under 1 Year (excl. Intgbl) 9.48 % Assets/Equity 1.11   Cash/Equity 24.89   (Liquidity Ratios) Net Working Capital to Total Assets 21.45 % Current Ratio 3.27   Quick Ratio (Acid Test) 3.27   Liquidity Ratio 2.36   Cash & Equiv/Current Assets 72.35 % (Solvency Ratios) Enterprise Value 2.07 m CFO/Sales -   CFO/Attributable Profit -   CFO/Assets -0.41   CFO/Debt -4.02   Total Debt/Equity Market Value 0.28   Total Debt/Sales -   Total Debt/Pre-Tax Profit -0.29   Total Debt 1.43 m Total Debt/Net Current Assets 0.47 % (Dodds - Graham Ratios) 3 yr Compound Earnings Growth - % 5 yr Compound Earnings Growth - % 10 yr Compound Earnings Growth - % Earn drops > 5% in 10yrs -   Beta (60-Mnth) Beta (36-Mnth) 1.7039 1.7039 Alpha (60-Mnth) Alpha (36-Mnth) -0.0060 -0.0060 Neuropharm Operating Ratios (Profitability Ratios) Return On Capital Employed (ROCE) -38.77 % Return On Assets (ROA) -25.99 % Net Profit Margin - % Assets Turnover -   Return On Equity (ROE) -33.11 % Return On Investment (ROI) -28.36 % Dividend Payout Ratio - % Plowback Ratio 100.00 % Growth from Plowback Ratio - % Net Income Of Revenues - % (Asset Utilisation Multiples) Shareholders Equity Turnover -   Fixed Assets Turnover -   Current Assets Turnover -   Net Working Capital Turnover -   Inventory Turnover -   (Other Operating Ratios) Total Assets-to-Sales -   Debtors-to-Sales - % Debt Collection Period - Days Neuropharm Dividends Announcement Date Type Curr. Dividend Amount Period Start Period End Ex Date Record Date Payment Date Total Dividend Amount - Final GBP - 06/30/2006 06/30/2007 - - - - - Final GBP - 06/30/2005 06/30/2006 - - - - 08 Dec 2004 Final GBP - 09/30/2003 09/30/2004 - - - 3.00 28 May 2004 Interim GBP 3.00 10/01/2003 03/31/2004 06/09/2004 06/11/2004 07/14/2004 - 11 Dec 2003 Final GBP 2.25 09/30/2002 09/30/2003 02/04/2004 02/06/2004 03/03/2004 3.00 03 Jun 2003 Interim GBP 0.75 09/30/2002 09/30/2003 06/11/2003 06/13/2003 07/14/2003 - - Final GBP - 09/30/2001 09/30/2002 - - - - - Final GBP - 09/30/2000 09/30/2001 - - - - - Final GBP - 09/30/1999 09/30/2000 - - - - 09 Dec 1999 Final GBP 3.20 09/30/1998 09/30/1999 01/04/2000 01/10/2000 01/25/2000 11.60 08 Sep 1999 Quarterly GBP 3.00 09/30/1998 09/30/1999 09/20/1999 09/24/1999 10/08/1999 - 03 Jun 1999 Quarterly GBP 2.80 09/30/1998 09/30/1999 06/28/1999 07/02/1999 07/09/1999 - 03 Mar 1999 Quarterly GBP 2.60 09/30/1998 09/30/1999 03/15/1999 03/19/1999 04/09/1999 - 25 Nov 1998 Final GBP 2.40 09/30/1997 09/30/1998 12/07/1998 12/11/1998 04/09/1999 8.40 Neuropharm Fundamentals   30 Jun 2007 (GBP) 30 Jun 2008 (GBP) turnover - -% - -% m pre tax profit -3.24 -% -4.95 -% m attributable profit -3.24 -% -4.19 -% m retained profit -3.24 -% -4.19 -% m eps - basic -16.60   -13.30   eps - diluted -16.60   -16.60   dividends per share -   -   Neuropharm Balance Sheet   30 Jun 2007 (GBP) 30 Jun 2008 (GBP)   30 Jun 2007 (GBP) 30 Jun 2008 (GBP) ASSETS  fixed assets 0.01 0.07% 0.18 1.28% m  intangibles 0.05 0.26% 0.04 0.30% m  fixed investments 12.01 66.08% 9.51 67.51% m  current assets - other - -% - -% m  stocks - -% - -% m  debtors 0.46 2.52% 1.20 8.55% m  cash & securities 5.65 31.08% 3.15 22.36% m TOTAL 18.17 100% 14.09 100% m LIABILITIES  creditors - short 1.37 7.51% 1.33 9.46% m  creditors - long 0.10 0.56% 0.10 0.69% m  creditors - other - -% - -% m  subordinated loans - -% - -% m  insurance funds - -% - -% m TOTAL 1.47 8.07% 1.43 10.14% m EQUITY  ord cap, reserves 16.70 91.93% 12.66 89.86% m  prefs, minorities - -% - -% m TOTAL 16.70 91.93% 12.66 89.86% m OTHER NAV Basic -   -   NAV Diluted -   -   Neuropharm Cash Flow Statement 30 Jun 2007 (GBP) 30 Jun 2008 (GBP) Operating CF -2.14 -5.74 m Pre-Financing CF -13.84 -2.55 m Retained CF 5.18 -2.55 m Neuropharm Brokers Name Activity Type Mnemonic Code Evolution Securities Limited Market Maker(MMF) Broker/Dealer EVO EVBGGB21MMT Investec Bank (uk) Ld Market Maker(MMF) Broker/Dealer INV. IHCSGB21002 Piper Jaffray Limited Market Maker(MMF) Broker/Dealer PIPR PIPRGB21 Winterflood Secs Ld Market Maker(MMF) Broker/Dealer WINS WNTSGB2LBIC

LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes. All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme Copyright1999-2009 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs

ADDITIONAL SERVICES AVAILABLE FROM ADVFN ADVFN Forex Channel Exchange Rates, FX Prices Charts, Forex Brokers & Currency Conversion

30 site:2us lse nph091122 05:15 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 )